Literature DB >> 27425608

Signal-Dependent Recruitment of BRD4 to Cardiomyocyte Super-Enhancers Is Suppressed by a MicroRNA.

Matthew S Stratton1, Charles Y Lin2, Priti Anand3, Philip D Tatman4, Bradley S Ferguson1, Sean T Wickers1, Amrut V Ambardekar1, Carmen C Sucharov1, James E Bradner5, Saptarsi M Haldar6, Timothy A McKinsey7.   

Abstract

BRD4 governs pathological cardiac gene expression by binding acetylated chromatin, resulting in enhanced RNA polymerase II (Pol II) phosphorylation and transcription elongation. Here, we describe a signal-dependent mechanism for the regulation of BRD4 in cardiomyocytes. BRD4 expression is suppressed by microRNA-9 (miR-9), which targets the 3' UTR of the Brd4 transcript. In response to stress stimuli, miR-9 is downregulated, leading to derepression of BRD4 and enrichment of BRD4 at long-range super-enhancers (SEs) associated with pathological cardiac genes. A miR-9 mimic represses stimulus-dependent targeting of BRD4 to SEs and blunts Pol II phosphorylation at proximal transcription start sites, without affecting BRD4 binding to SEs that control constitutively expressed cardiac genes. These findings suggest that dynamic enrichment of BRD4 at SEs genome-wide serves a crucial role in the control of stress-induced cardiac gene expression and define a miR-dependent signaling mechanism for the regulation of chromatin state and Pol II phosphorylation.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27425608      PMCID: PMC4972677          DOI: 10.1016/j.celrep.2016.06.074

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  48 in total

1.  A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis.

Authors:  M Olive; D Krylov; D R Echlin; K Gardner; E Taparowsky; C Vinson
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.

Authors:  Marta Fierro-Fernández; Óscar Busnadiego; Pilar Sandoval; Cristina Espinosa-Díez; Eva Blanco-Ruiz; Macarena Rodríguez; Héctor Pian; Ricardo Ramos; Manuel López-Cabrera; Maria Laura García-Bermejo; Santiago Lamas
Journal:  EMBO Rep       Date:  2015-08-27       Impact factor: 8.807

3.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

4.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

5.  Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.

Authors:  Denes Hnisz; Jurian Schuijers; Charles Y Lin; Abraham S Weintraub; Brian J Abraham; Tong Ihn Lee; James E Bradner; Richard A Young
Journal:  Mol Cell       Date:  2015-03-19       Impact factor: 17.970

6.  Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells.

Authors:  Erik Arner; Carsten O Daub; Kristoffer Vitting-Seerup; Robin Andersson; Berit Lilje; Finn Drabløs; Andreas Lennartsson; Michelle Rönnerblad; Olga Hrydziuszko; Morana Vitezic; Tom C Freeman; Ahmad M N Alhendi; Peter Arner; Richard Axton; J Kenneth Baillie; Anthony Beckhouse; Beatrice Bodega; James Briggs; Frank Brombacher; Margaret Davis; Michael Detmar; Anna Ehrlund; Mitsuhiro Endoh; Afsaneh Eslami; Michela Fagiolini; Lynsey Fairbairn; Geoffrey J Faulkner; Carmelo Ferrai; Malcolm E Fisher; Lesley Forrester; Daniel Goldowitz; Reto Guler; Thomas Ha; Mitsuko Hara; Meenhard Herlyn; Tomokatsu Ikawa; Chieko Kai; Hiroshi Kawamoto; Levon M Khachigian; S Peter Klinken; Soichi Kojima; Haruhiko Koseki; Sarah Klein; Niklas Mejhert; Ken Miyaguchi; Yosuke Mizuno; Mitsuru Morimoto; Kelly J Morris; Christine Mummery; Yutaka Nakachi; Soichi Ogishima; Mariko Okada-Hatakeyama; Yasushi Okazaki; Valerio Orlando; Dmitry Ovchinnikov; Robert Passier; Margaret Patrikakis; Ana Pombo; Xian-Yang Qin; Sugata Roy; Hiroki Sato; Suzana Savvi; Alka Saxena; Anita Schwegmann; Daisuke Sugiyama; Rolf Swoboda; Hiroshi Tanaka; Andru Tomoiu; Louise N Winteringham; Ernst Wolvetang; Chiyo Yanagi-Mizuochi; Misako Yoneda; Susan Zabierowski; Peter Zhang; Imad Abugessaisa; Nicolas Bertin; Alexander D Diehl; Shiro Fukuda; Masaaki Furuno; Jayson Harshbarger; Akira Hasegawa; Fumi Hori; Sachi Ishikawa-Kato; Yuri Ishizu; Masayoshi Itoh; Tsugumi Kawashima; Miki Kojima; Naoto Kondo; Marina Lizio; Terrence F Meehan; Christopher J Mungall; Mitsuyoshi Murata; Hiromi Nishiyori-Sueki; Serkan Sahin; Sayaka Nagao-Sato; Jessica Severin; Michiel J L de Hoon; Jun Kawai; Takeya Kasukawa; Timo Lassmann; Harukazu Suzuki; Hideya Kawaji; Kim M Summers; Christine Wells; David A Hume; Alistair R R Forrest; Albin Sandelin; Piero Carninci; Yoshihide Hayashizaki
Journal:  Science       Date:  2015-02-12       Impact factor: 47.728

Review 7.  HDAC-dependent ventricular remodeling.

Authors:  Min Xie; Joseph A Hill
Journal:  Trends Cardiovasc Med       Date:  2013-03-15       Impact factor: 6.677

8.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

9.  Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.

Authors:  Shwu-Yuan Wu; A-Young Lee; Hsien-Tsung Lai; Hong Zhang; Cheng-Ming Chiang
Journal:  Mol Cell       Date:  2013-01-11       Impact factor: 17.970

10.  Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.

Authors:  Jolyane Meloche; François Potus; Mylène Vaillancourt; Alice Bourgeois; Ian Johnson; Laure Deschamps; Sophie Chabot; Grégoire Ruffenach; Sarah Henry; Sandra Breuils-Bonnet; Ève Tremblay; Valérie Nadeau; Caroline Lambert; Renée Paradis; Steeve Provencher; Sébastien Bonnet
Journal:  Circ Res       Date:  2015-07-29       Impact factor: 17.367

View more
  35 in total

1.  BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy.

Authors:  Andrew Antolic; Hiroko Wakimoto; Zhe Jiao; Joshua M Gorham; Steven R DePalma; Madeleine E Lemieux; David A Conner; Da Young Lee; Jun Qi; Jonathan G Seidman; James E Bradner; Jonathan D Brown; Saptarsi M Haldar; Christine E Seidman; Michael A Burke
Journal:  JCI Insight       Date:  2020-08-06

Review 2.  Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts.

Authors:  Cameron S Brand; Janet K Lighthouse; Michael A Trembley
Journal:  J Mol Cell Cardiol       Date:  2019-04-28       Impact factor: 5.000

Review 3.  Targeting transcriptional machinery to inhibit enhancer-driven gene expression in heart failure.

Authors:  Rachel A Minerath; Duane D Hall; Chad E Grueter
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

4.  The potential of targeting epigenetic regulators for the treatment of fibrotic cardiac diseases.

Authors:  Katherine B Schuetze; Keith A Koch; Timothy A McKinsey
Journal:  Future Med Chem       Date:  2016-08-24       Impact factor: 3.808

Review 5.  Short and Long Noncoding RNAs Regulate the Epigenetic Status of Cells.

Authors:  Shizuka Uchida; Roberto Bolli
Journal:  Antioxid Redox Signal       Date:  2017-09-28       Impact factor: 8.401

6.  Differential Activation of P-TEFb Complexes in the Development of Cardiomyocyte Hypertrophy following Activation of Distinct G Protein-Coupled Receptors.

Authors:  Ryan D Martin; Yalin Sun; Sarah MacKinnon; Luca Cuccia; Viviane Pagé; Terence E Hébert; Jason C Tanny
Journal:  Mol Cell Biol       Date:  2020-06-29       Impact factor: 4.272

Review 7.  The therapeutic potential of BRD4 in cardiovascular disease.

Authors:  Shigang Lin; Lizhong Du
Journal:  Hypertens Res       Date:  2020-05-14       Impact factor: 3.872

8.  Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.

Authors:  Matthew S Stratton; Rushita A Bagchi; Marina B Felisbino; Rachel A Hirsch; Harrison E Smith; Andrew S Riching; Blake Y Enyart; Keith A Koch; Maria A Cavasin; Michael Alexanian; Kunhua Song; Jun Qi; Madeleine E Lemieux; Deepak Srivastava; Maggie P Y Lam; Saptarsi M Haldar; Charles Y Lin; Timothy A McKinsey
Journal:  Circ Res       Date:  2019-08-14       Impact factor: 17.367

9.  BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.

Authors:  Qiming Duan; Sarah McMahon; Priti Anand; Hirsh Shah; Sean Thomas; Hazel T Salunga; Yu Huang; Rongli Zhang; Aarathi Sahadevan; Madeleine E Lemieux; Jonathan D Brown; Deepak Srivastava; James E Bradner; Timothy A McKinsey; Saptarsi M Haldar
Journal:  Sci Transl Med       Date:  2017-05-17       Impact factor: 17.956

10.  Class I HDACs control a JIP1-dependent pathway for kinesin-microtubule binding in cardiomyocytes.

Authors:  Weston W Blakeslee; Ying-Hsi Lin; Matthew S Stratton; Philip D Tatman; Tianjing Hu; Bradley S Ferguson; Timothy A McKinsey
Journal:  J Mol Cell Cardiol       Date:  2017-09-05       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.